These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14808297)

  • 41. The intensity and duration of the effect of depo-heparin on venous coagulation time in man.
    MOSS H; D'ALESSANDRO DR
    Am Pract Dig Treat; 1951 Apr; 2(4):309-10. PubMed ID: 14819525
    [No Abstract]   [Full Text] [Related]  

  • 42. Development of a fluorescent method for detecting the onset of coagulation in human plasma on microstructured lateral flow platforms.
    Dudek MM; Kent NJ; Gu P; Fan ZH; Killard AJ
    Analyst; 2011 May; 136(9):1816-25. PubMed ID: 21293802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.
    INNES D; SEVITT S
    J Clin Pathol; 1964 Jan; 17(1):1-13. PubMed ID: 14103515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [EFFECT OF SURGERY ON BLOOD COAGULATION].
    ZYKAS V
    Sveikatos Apsauga; 1963 Dec; 8():8-13. PubMed ID: 14111268
    [No Abstract]   [Full Text] [Related]  

  • 47. Viscoelastic blood coagulation measurement with Sonoclot predicts postoperative bleeding in cardiac surgery after heparin reversal.
    Bischof DB; Ganter MT; Shore-Lesserson L; Hartnack S; Klaghofer R; Graves K; Genoni M; Hofer CK
    J Cardiothorac Vasc Anesth; 2015; 29(3):715-22. PubMed ID: 25864405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relation between heparin blood levels and blood coagulation times.
    MONKHOUSE FC; MACMILLAN RL; BROWN KW
    J Lab Clin Med; 1953 Jul; 42(1):92-7. PubMed ID: 13061833
    [No Abstract]   [Full Text] [Related]  

  • 49. [Behavior of coagulation time of blood in normal and pathological subjects following intravenous administration of heparin (De Takats test)].
    DOTTI F; BONORA G
    Rass Int Clin Ter; 1950 Jun; 30(12):364-5. PubMed ID: 14781388
    [No Abstract]   [Full Text] [Related]  

  • 50. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of aureomycin on the clotting time of the blood.
    SHAPSE JB; WRIGHT LT
    Angiology; 1950 Aug; 1(4):306-11. PubMed ID: 15432961
    [No Abstract]   [Full Text] [Related]  

  • 52. Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
    PEEL AA
    Br Heart J; 1956 Jul; 18(3):378-84. PubMed ID: 13342301
    [No Abstract]   [Full Text] [Related]  

  • 53. [BLOOD COAGULATION IN HYPERTENSION].
    URANIUK KG
    Klin Med (Mosk); 1963 Aug; 41():38-42. PubMed ID: 14086885
    [No Abstract]   [Full Text] [Related]  

  • 54. [CHANGES IN BLOOD COAGULATION IN ISCHEMIC CORONARY STATES DETERMINED BY THE HEPARIN TOLERANCE TEST].
    SVEHLA C; SVORCIK C; SLIZ K; SPANKOVA H; MLEJNKOVA M; BAMBASOVA Z
    Cas Lek Cesk; 1964 May; 103():597-600. PubMed ID: 14167009
    [No Abstract]   [Full Text] [Related]  

  • 55. [DISORDERS OF BLOOD COAGULATION IN BURNS].
    LINTILHAC JP; SABLAYROLLES D
    Maroc Med; 1963 Sep; 42():679-81. PubMed ID: 14052111
    [No Abstract]   [Full Text] [Related]  

  • 56. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
    Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
    J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Coagulation time in subcutaneous heparin treatment].
    von AHN
    Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141
    [No Abstract]   [Full Text] [Related]  

  • 58. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood recalcification time. A simple and reliable test to monitor heparin therapy.
    Gulliani GL; Hyun BH; Litten MB
    Am J Clin Pathol; 1976 Mar; 65(3):390-6. PubMed ID: 1258831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparinization during percutaneous cardiac catheterization in children.
    Netz H; Madu B; Röhner G
    Pediatr Cardiol; 1987; 8(3):167-8. PubMed ID: 3432104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.